The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

Fortress is offering 310p per share, valuing the total equity of the company at around £338 million ($428 million; €406 ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...

Grifols said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks ...

Plus, Brookfield drops deal for Spanish healthcare group Grifols and Sequoia Capital’s spun-off China unit hunts for global deals ...

FRANKFURT: French stocks hit a more than three-month low on Wednesday as investors fretted about the fragile government’s ...

EUROPEAN equities fell as concerns mounted around the French government’s ability to push through its budget plan. Read more ...

European shares finished a tad lower on Wednesday as the spectre of high US tariffs threatened by President-elect Donald ...